Showing results (421-430 of 492) with videos related to
Sort By:
Pageof 50
Annals of Neurology|March 11, 2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseAlexis Elbaz, Owen A Ross, John P A Ioannidis, et al.Neurology|September 16, 2016
A genome-wide association study in multiple system atrophyAnna Sailer, Sonja W Scholz, Michael A Nalls, et al.Human Molecular Genetics|November 13, 2013
DNAJC13 mutations in Parkinson diseaseCarles Vilariño-Güell, Alex Rajput, Austen J Milnerwood, et al.Neurobiology of Aging|December 9, 2015
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseasesRita Guerreiro, Valentina Escott-Price, Lee Darwent, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 5, 2015
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's diseaseChristina M Lill, Aina Rengmark, Lasse Pihlstrøm, et al.The Lancet. Neurology|November 9, 2019
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studiesMike A Nalls, Cornelis Blauwendraat, Costanza L Vallerga, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohortsHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.Science Translational Medicine|September 29, 2021
APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementiaChia-Chen Liu, Melissa E Murray, Xia Li, et al.Neurobiology of Aging|December 27, 2016
ATXN2 trinucleotide repeat length correlates with risk of ALSWilliam Sproviero, Aleksey Shatunov, Daniel Stahl, et al.Plos One|September 7, 2012
Creation of an open-access, mutation-defined fibroblast resource for neurological disease researchSelina Wray, Matthew Self, , et al.Pageof 50